Michael S. Rosol - Jan 14, 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Chief Medical Officer
Signature
/s/ Erika L. Eves for Michael S. Rosol, by power of attorney
Stock symbol
NAVB
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 08:28 AM
Previous filing
Mar 8, 2022
Next filing
Sep 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +7.73K +112.87% $0.00 14.6K Jan 14, 2022 Direct F1
holding NAVB Common Stock 6.82K Jan 14, 2022 Held by 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus, as elected by the Reporting Person.